Delivery Order SPE2DB22D2009-SPE2DB25FL9VM
Award Date
6/24/25
Potential Completion Date
6/25/25
Potential Value
$81K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML medical products. The contract has a firm fixed price of $2,549.46 and a period of performance through June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $11,780.40 and a performance period through June 4, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,375.41 and a period of performance through May 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,040.85 and a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a total ceiling value of $5,637.40. The contract has a performance period through June 13, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has a ceiling value of $1,256.33 and an ultimate completion date of June 23, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $2,408.46 and a period of performance through May 9, 2025. The contract is a Firm Fixed Price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML medical supplies, with a ceiling value of $4,554.94 and a period of performance through March 27, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract is a firm fixed price delivery order with a ceiling value of $1,401.52 and a period of performance through June 11, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML VIAL. The contract has a ceiling value of $1,872.18 and an ultimate completion date of May 29, 2025. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides pharmaceutical and medical supply support to the Defense Health Agency, U.S....